Highlights Sprint Bioscience AB

Equities

SPRINT

SE0006343745

Market Closed - Nasdaq Stockholm Other stock markets 11:29:37 2024-05-17 am EDT			5-day change	1st Jan Change
1.24 ^SEK	-6.49%		-11.43%	-28.53%

May. 08	Sprint Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Feb. 14	Sprint Bioscience AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sprint Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08	CI
Sprint Bioscience AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 14	CI
Sprint Bioscience AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 14	CI
Sprint Bioscience AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-25	CI
Sprint Bioscience AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-24	CI
Sprint Bioscience Licenses the Vada Program to Day One Biopharmaceuticals	23-08-16	CI
Sprint Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Sprint Bioscience AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-15	CI
Sprint Bioscience AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-15	CI
Sprint Bioscience Reports Novel AMLarget Proteins in Ongoing Collaboration	22-11-08	CI
Sprint Bioscience AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-26	CI
Sprint Bioscience AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-24	CI
Sprint Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-11	CI
Sprint Bioscience Launches NIMA at BIO International	22-05-05	CI
Sprint Bioscience AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	22-02-16	CI
Sprint Bioscience AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-10-27	CI
Sprint Bioscience AB Initiates Marketing of an Additional Cancer Drug Program	21-09-27	CI
Sprint Bioscience AB Adds New Cancer Drug Program to its Project Portfolio	21-09-08	CI
Sprint Bioscience AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-13	CI
Sprint Bioscience Licenses the Cancer Drug Program Vps34 to Deciphera Pharmaceuticals	21-08-03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sprint Bioscience AB

Equities

SPRINT

SE0006343745

Highlights

Filters